5 Amino 1 MQ
Typical Dosage
50-150 mg/500mcg-1mg
Administration
Oral
Half-Life
Not well characterized in humans
Mechanism of Action
NNMT inhibition|Adiposity and body-composition studies|Insulin-sensitivity models|NAD+ salvage/metabolic research
Research Protocol Summary
Evidence Level
Preclinical
Typical Protocol Duration
4-8 weeks
Species Studied
Mouse • Rat
Administration Schedule
5 X Week
Timing Notes
AM
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…